The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels: Human in vivo measurements | PLOS ONE
SYMKEVI (tezacaftor/ivacaftor) - Wiki | Golden
Frontiers | Comprehensive Analysis of Chemical Structures That Have Been Tested as CFTR Activating Substances in a Publicly Available Database CandActCFTR
The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients | PLOS ONE
The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients | PLOS ONE
Cystic fibrosis - Wikiwand
Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects - Kelly Kuk, Jennifer L. Taylor-Cousar, 2015
Outcomes and Tolerances in Cystic Fibrosis Treatment Lumacaftor/Ivacaftor
Impact of the CFTR-Potentiator Ivacaftor on Airway Microbiota in Cystic Fibrosis Patients Carrying A G551D Mutation | PLOS ONE
Ivacaftor (VX 770, CAS Number: 873054-44-5) | Cayman Chemical
101831-37-2 | Diclazuril | 2,6-Dichloro-α-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile; Clinacox; Nuoqiu; P 64433; R 64433; Vecoxan; | C₁₇H₉Cl₃N₄O₂ | TRC
Glycemia and β-cell function before and after elexacaftor/tezacaftor/ ivacaftor in youth and adults with cystic fibrosis - ScienceDirect
Pyrilutamide - Wikipedia
Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects - Kelly Kuk, Jennifer L. Taylor-Cousar, 2015